Debiopharm Innovation Fund
Venture capitalLausanne · Series A–Late Stage · 5 people tracked
Team · 5 people
from the firm's websiteFrequently asked questions
- What stage does Debiopharm Innovation Fund invest at?
- Debiopharm Innovation Fund invests at the Series A, Series B, Late Stage stages.
- What is Debiopharm Innovation Fund's typical check size?
- Debiopharm Innovation Fund typically writes checks of $3M – $5M.
- What sectors does Debiopharm Innovation Fund focus on?
- Debiopharm Innovation Fund focuses on Biotech, Healthtech.
- Where is Debiopharm Innovation Fund located?
- Debiopharm Innovation Fund is headquartered in Lausanne, CH.
Similar investors
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.